Using one of the only FDA-cleared algorithms, Biofourmis accelerates pharmaceutical product innovation and clinical research with a holistic, end-to-end solution to help improve patient outcomes.
Our proven remote patient management, integrated technology platform, and passion for data science provide you access to new clinical insights and reach a more inclusive patient population.
Individual biometric data and machine learning algorithms enable objective clinical measures and generate new patient insights to drive personalized care.
50+ in-house data scientists for development of proprietary algorithms to support new novel digital biomarkers
Gain longitudinal insights into disease progression for an individual patient, or for a collective population
Pre-validated wearable biosensors and connected devices, seamlessly integrated with our proprietary Biovitals platform
We partner with leading biopharmaceutical companies in the development of clinically-validated software-based therapeutics and digital patient engagement programs.
Satoko Shisai, Chugai’s Vice President, Head of Digital & IT Supervisory Division
Our digital medicine portfolio covers a range of patient conditions, including heart failure, acute coronary syndrome, COPD, oncology, and chronic pain.
© 2023 Biofourmis. All rights reserved | Privacy Policy | Website Terms